
Please try another search
Jiangsu Nhwa Pharmaceutical Co., LTD engages in production, marketing, and services related to central nervous system drugs in China. It’s product portfolio includes Duloxetine Hcl, Risperidone, Ziprasidone Hcl, Etomidate Fat Emulsion, Gabapentin, Zaleplon, etc.; and Iptakalim, an anti-hypertension drug. The company’s products are used for treatment of anesthesiology, psychiatry and neurology, as well as APIs. Jiangsu Nhwa Pharmaceutical Co., LTD was founded in 1978 and is headquartered in Xuzhou, China.
Name | Age | Since | Title |
---|---|---|---|
Yulan Li | - | 2022 | Independent Director |
Jiaquan Sun | 48 | 2010 | GM & Non-Independent Director |
Ziliang Yang | 60 | 2007 | Deputy GM & Non-Independent Director |
Pengsheng Sun | 66 | 2007 | Non-Independent Chairman of the Board |
Qing Fu | 63 | 2007 | Deputy GM & Non-Independent Director |
Fengshou Wang | 63 | 2007 | Chairman of the Supervisory Board |
Zengliang Chen | 61 | 2007 | Deputy GM & Non-Independent Director |
Xiaoxing Yin | 59 | 2022 | Independent Director |
Xinglei Jia | 56 | 2007 | Member of the Supervisory Board |
Guoxiang Chen | 60 | 2022 | Independent Director |
Xiao Chen Qian | 62 | 2007 | Employee Representative Member of Supervisory Board |
Yu Lan Li | 74 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review